Enalapril: a new angiotensin converting enzyme inhibitor

JD Cleary, JW Taylor - Drug intelligence & clinical pharmacy, 1986 - journals.sagepub.com
Enalapril maleate is a new angiotensin converting enzyme inhibitor marketed in the US by
Merck Sharp and Dohme. It has been demonstrated to actively interfere with the renin …
被引用次数：46 相关文章

Enalapril: a new angiotensin converting enzyme inhibitor.

JD Cleary, JW Taylor - Drug Intelligence & Clinical Pharmacy, 1986 - europepmc.org
Enalapril maleate is a new angiotensin converting enzyme inhibitor marketed in the US by
Merck Sharp and Dohme. It has been demonstrated to actively interfere with the renin …

[引用][C] Enalapril: a new angiotensin converting enzyme inhibitor

JD CLEARY, JW TAYLOR - Drug intelligence & clinical …, 1986 - pascal-francis.inist.fr
Enalapril: a new angiotensin converting enzyme inhibitor CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

Enalapril: a new angiotensin converting enzyme inhibitor

JD Cleary, JW Taylor - Drug intelligence & clinical …, 1986 - pubmed.ncbi.nlm.nih.gov
Enalapril maleate is a new angiotensin converting enzyme inhibitor marketed in the US by
Merck Sharp and Dohme. It has been demonstrated to actively interfere with the renin …

[引用][C] Enalapril: a new angiotensin converting enzyme inhibitor

JD CLEARY, JW TAYLOR - Drug …, 1986 - Drug Intelligence and Clinical …